Chronic pain
https://doi.org/10.14412/2074-2711-2010-107
Abstract
Due to its high prevalence and diversity of its forms, chronic neocancer pain is noted to have become a serious medical problem. Chronic pain is regarded as an independent disease, not a symptom of any disease, which calls for special attention and complex etiopathogenetic treatment.
The paper gives the characteristics and causes of pain syndromes and an algorithm for the treatment of chronic pain. It is stated that treating patients with chronic neocancer pain requires that its clinical features be kept in mind; moreover, treatment should be itself safe and effective. Drugs must be used for a long period, by strictly following the schedule in individual doses.
The paper gives the characteristics and causes of pain syndromes and an algorithm for the treatment of chronic pain. It is stated that treating patients with chronic neocancer pain requires that its clinical features be kept in mind; moreover, treatment should be itself safe and effective. Drugs must be used for a long period, by strictly following the schedule in individual doses.
About the Author
M. L. Kukushkin
Research Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences
Russian Federation
Moscow
Russian Federation
Moscow
References
1. <div><p>Breivik H., Collett В., Ventafridda V. et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.</p><p>Вјоrk M., Sand T. Quantitative EEG power and asymmetry increase 36 h before a migraine attack. Cephalalgia 2008;2:212-8.</p><p>Кукушкин М.Л., Хитров Н.К. Общая патология боли. М.: Медицина, 2004;144 с.</p><p>Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms /prepared by International Association for the Study of Pain, Task Force on Taxonomy; ed H. Merskey, N. Bogduk. 2nd ed. Seattle: IASP Press, 1994;222 р. Wall and Melzack's Textbook of Pain. 5th ed.</p><p>B. McMahon, M. Koltzenburg (eds). Elsevier Churchill Livingstone, 2005;1239 p.</p><p>Treede R.D., Jensen T.S., Campbell G.N. et al. Neuropathic pain: redefinition and a grading system for clinical and research diagnostic purposes. Neurology 2008;70:3680-5.</p><p>Данилов А.Б., Давыдов О.С. Нейропатическая боль. М.: Боргес, 2007;192 с.</p><p>Яхно Н.Н., Кукушкин М.Л., Данилов А.Б. и др. Результаты Российского эпидемиологического исследования распространенности невропатической боли, ее причин и характеристик в популяции амбулаторных больных, обратившихся к врачу-неврологу. Боль 2008;3:24-32.</p><p>Attal N., Cruccu G., Haanpaa M. et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-69.</p><p>Бреговский В.Б. Болевые формы диабетической полиневропатии нижних конечностей: современные представления и возможности лечения (обзор литературы). Боль 2008;1:29-34.</p><p>Davies M., Brophy S., Williams R. et al. The Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes. Diabetes Care 2006;29:1518-22.</p><p>Пшенникова М.Г., Смирнова В.С., Графова В.Н. и др. Устойчивость к развитию невропатического болевого синдрома у крыс линии август и популяции вистар, обладающих разной врожденной устойчивостью к стрессовому воздействию. Боль 2008;2:13-6.</p><p>Bernatsky S., Dobkin P. L., De Civita M. et al. Comorbidity and physician use in fibromyalgia. Swiss Med Wkly 2005;135:76-81.</p><p>Ritzwoller D.P., Crounse L., Shetterly S. et al. The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskeletal Disorders 2006;7:72-82.</p><p>Stang P., Brandenburg N., Lane M. et al. Mental and Physical Comorbid Conditions and Days in Role Among Persons with Arthritis. Psychosom Med 2006;68(1):152-8.</p><p>Nackley-Neely A.G., Tan K.S., Fecho K. et al. Catechol-O-methyltransferase Inhibition Increases Pain Sensitivity through Activation of Both β2 and β3 Adrenergic Receptors. Pain 2007;128(3):199-208.</p><p>Sarnthein J., Stern J., Aufenberg C. et al. Increased EEG power and slowed dominant frequency in patients with neurogenic pain. Brain 2006;129:55-64.</p><p>Дизрегуляционная патология. Под ред. акад. РАМН Г.Н. Крыжановского. М.: Медицина, 2002;632 с.</p><p>Mannisto P.T., Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999;51:593-628.</p><p>Diatchenko L., Slade G.D., Nackley A.G. et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005;14(1):135-43.</p><p>Gursoy S., Erdal E., Herken H. et al. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheum Int 2003;23:104-7.</p><p>Крупина Н.А., Малахова Е.В., Лоранская И.Д. и др. Анализ электрической активности мозга у больных с дисфункциями желчного пузыря. Боль 2005;3:34-41.</p><p>Крупина Н.А., Хадзегова Ф.Р., Майчук Е.Ю. и др. Анализ электрической активности мозга у больных с синдромом раздраженной кишки. Боль 2008;2:6-12.</p><p>Lia C., Carenini L., Degioz C. et al. Computerized EEG analysis in migraine patients. Ital J Neurol Sci 1995;16(4):249-54.</p><p>Каратеев А.Е. Гастродуоденальная безопасность селективных ингибиторов циклооксигеназы-2: проверка практикой. Тер арх 2005;5:69-72.</p></div><br />
Review
For citations:
Kukushkin M.L. Chronic pain. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(3):80-86. (In Russ.) https://doi.org/10.14412/2074-2711-2010-107
Views: 1393
Email this article 